Evidence map›Paper›PMID 27468760›Full record

ArticleJournal of leukocyte biology2017

Frontline Science: Coincidental null mutation of Csf2rα in a colony of PI3Kγ-/- mice causes alveolar macrophage deficiency and fatal respiratory viral infection.

Christoph Schneider, Samuel P Nobs, Alex K Heer, Emilio Hirsch, Josef Penninger, Owen M Siggs, Manfred Kopf

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Journal of leukocyte biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04400929 (Using GM-CSF as a Host Directed Therapeutic Against COVID-19 - a Phase 2 Investigator Initiated Trial), which is not on this map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04400929 phase2completednot on this mapstarted 2020, after this paper: background citation

Using GM-CSF as a Host Directed Therapeutic Against COVID-19 - a Phase 2 Investigator Initiated Trial

TypeinterventionalSponsorSingapore General HospitalRan2020 to 2022Enrolled2ConditionsCOVID, Sars-CoV2, ARDS, HumanArmsSargramostim, Normal Saline 0.9%
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Recruited atypical Ly6GScience immunology · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Targeting cell signaling in allergic asthma.Signal transduction and targeted therapy
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 4 countries.

Christoph SchneiderInstitute of Molecular Health Sciences, Department of Biology, ETH Zurich, Zurich, Switzerland.
Samuel P NobsInstitute of Molecular Health Sciences, Department of Biology, ETH Zurich, Zurich, Switzerland.
Alex K HeerInstitute of Molecular Health Sciences, Department of Biology, ETH Zurich, Zurich, Switzerland.
Emilio HirschDepartment of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.
Josef PenningerInstitute of Molecular Biotechnology, Vienna, Austria; and.
Owen M SiggsWellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom.
Manfred KopfInstitute of Molecular Health Sciences, Department of Biology, ETH Zurich, Zurich, Switzerland; manfred.kopf@ethz.ch.
ETH Zurich · CHInstitute of Molecular Biotechnology · ATUniversity of Turin · ITWellcome Sanger Institute · GB

Funding

Wellcome Trust 100083
6 · The paper itself

Abstract

PI3Ks have been identified as key signaling proteins involved in many basic biologic processes in health and disease. Transgenic animals have been essential tools to study the underlying molecular mechanisms in this context and therefore, have been widely used to elucidate the role of these factors in many different settings. More specifically, PI3Kγ, a subunit highly expressed in the hematopoietic system, has been implicated to play an important role in many inflammatory diseases as well as cancer. Here, we report identification of multiple, additional, previously unknown mutations in the genome of a widely used PI3Kγ-deficient (PI3Kγ

Indexed as

AnimalsClass Ib Phosphatidylinositol 3-KinaseCrosses, GeneticDisease SusceptibilityFemaleGranulocyte-Macrophage Colony-Stimulating FactorMacrophages, AlveolarMaleMice, Inbred C57BLMice, KnockoutMutationOrthomyxoviridaeOrthomyxoviridae InfectionsReceptors, Granulocyte-Macrophage Colony-Stimulating FactorRespiratory Tract DiseasesSignal TransductionClass Ib Phosphatidylinositol 3-KinaseGranulocyte-Macrophage Colony-Stimulating FactorPik3cg protein, mouseReceptors, Granulocyte-Macrophage Colony-Stimulating FactorGM-CSF receptorinfluenzamucin 2PI3K

Identifiers

PMID27468760
PMCPMC5610570
OpenAlexW2486276507

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.